Previous close | 0.6000 |
Open | 0.6100 |
Bid | 0.4305 x 200 |
Ask | 0.7930 x 200 |
Day's range | 0.6000 - 0.6440 |
52-week range | 0.0800 - 9.4900 |
Volume | |
Avg. volume | 1,577,240 |
Market cap | 11.378M |
Beta (5Y monthly) | 1.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1800 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
KUALA LUMPUR, Malaysia, April 19, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), a global leader in genomic diagnostics and healthcare technology, announces a strategic investment by its wholly owned subsidiary, MRNA Scientific Sdn Bhd, in Ascension Innovation Sdn Bhd (AISB), a privately held Malaysian company. This investment underscores BGLC’s commitment to advancing healthcare solutions through cutting-edge AI and predictive analytics. Background: MRNA Scientific Sdn B
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...